Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyclophosphamide (cytoxan) (1 trial)
fludarabine (fludara) (1 trial)
invac-1 (2 trials)
ivs-3001 (1 trial)
ucpvax (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lung Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (5 total)